The pro-apoptotic activity of isatuximab in the absence of cross-linking agents was seen in MOLP-8 MM cell lines, which have high levels of CD38 RD (790,000 molecules/cell) [13]. This evidence concerns the gene CD38 and Miyoshi myopathy.